4.5 (576) In stock
A Barbara Ann Karmanos Cancer Institute clinical researcher and her team have received $16,000 to further research in precision medicine for breast cancer treatment. Common Citizen leadership delivered the check to Jailan Elayoubi, M.D. , medical oncologist and member of the Breast Cancer and Phase 1 Clinical Trials Multidisciplinary Teams, in November 2023. Dr. Elayoubi and her team have made significant strides in studying biomarkers and tumor molecular characteristics that may predict sensitivity and
IJMS, Free Full-Text
Planning begins for new digital resource and seminars to help cancer patients navigate financial barriers, thanks to MHEF grant
IJMS, Free Full-Text
Halabi et al KCJ19n3 2021
Cancer Biomarkers: Powering Precision Medicine
Company Profile: HistoRx: tissue-based diagnostic solutions for
Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing
Lasting bond and exceptional care through genetic counseling leads to rekindled friendship decades later
Biomarker-Driven Clinical Trials
Barbara Ann Karmanos Cancer Institute
